Atrial myxoma presenting with orthostatic hypotension in an 84-year-old Hispanic man: a case report

Ralph M Vicari1, Enrique Polanco, Norberto Schechtmann

  • 1Mima Century Research, E. Sheridan Rd, Melbourne, FL 32901, USA.

Insights

An 84-year-old man

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Diagnostic Imaging

Background:

  • Left atrial myxomas are the most common benign primary cardiac tumors.
  • They can mimic other conditions like mitral stenosis or infective endocarditis.
  • Atrial myxomas can cause serious complications including embolization and valve obstruction.

Purpose of the Study:

  • To report a case of atrial myxoma presenting atypically with orthostatic hypotension.
  • To highlight the utility of echocardiography in diagnosing intracardiac tumors.
  • To suggest echocardiography in the workup of unexplained orthostatic hypotension.

Main Methods:

  • Case presentation of an 84-year-old male with dizziness.
  • Physical examination revealing orthostatic hypotension.
  • Diagnostic workup including transthoracic echocardiogram and cardiac catheterization.
  • Surgical excision of the atrial myxoma.

Main Results:

  • A large left atrial myxoma (7 x 6.5 x 4.5 cm) was identified.
  • The tumor was attached by a stalk of atrial septal tissue.
  • The myxoma caused eccentric mitral regurgitation.

Conclusions:

  • Atrial myxomas can present with unusual symptoms like orthostatic hypotension.
  • Two-dimensional echocardiography is highly effective for detecting intracardiac tumors.
  • Echocardiography should be considered in the evaluation of unexplained orthostatic hypotension.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...